Unknown

Dataset Information

0

Active-target T1-weighted MR Imaging of Tiny Hepatic Tumor via RGD Modified Ultra-small Fe3O4 Nanoprobes.


ABSTRACT: Developing ultrasensitive contrast agents for the early detection of malignant tumors in liver is highly demanded. Constructing hepatic tumors specific targeting probes could provide more sensitive imaging information but still faces great challenges. Here we report a novel approach for the synthesis of ultra-small Fe3O4 nanoparticles conjugated with c(RGDyK) and their applications as active-target T1-weighted magnetic resonance imaging (MRI) contrast agent (T1-Fe3O4) for imaging tiny hepatic tumors in vivo. RGD-modified T1-Fe3O4 nanoprobes exhibited high r1 of 7.74 mM(-1)s(-1) and ultralow r2/r1 of 2.8 at 3 T, reflecting their excellent T1 contrast effect at clinically relevant magnetic field. High targeting specificity together with favorable biocompatibility and strong ability to resist against non-specific uptake were evaluated through in vitro studies. Owing to the outstanding properties of tumor angiogenesis targeting with little phagocytosis in liver parenchyma, hepatic tumor as small as 2.2 mm was successfully detected via the T1 contrast enhancement of RGD-modified T1-Fe3O4. It is emphasized that this is the first report on active-target T1 imaging of hepatic tumors, which could not only significantly improve diagnostic sensitivity, but also provide post therapeutic assessments for patients with liver cancer.

SUBMITTER: Jia Z 

PROVIDER: S-EPMC4997236 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Active-target T1-weighted MR Imaging of Tiny Hepatic Tumor via RGD Modified Ultra-small Fe3O4 Nanoprobes.

Jia Zhengyang Z   Song Lina L   Zang Fengchao F   Song Jiacheng J   Zhang Wei W   Yan Changzhi C   Xie Jun J   Ma Zhanlong Z   Ma Ming M   Teng Gaojun G   Gu Ning N   Zhang Yu Y  

Theranostics 20160715 11


Developing ultrasensitive contrast agents for the early detection of malignant tumors in liver is highly demanded. Constructing hepatic tumors specific targeting probes could provide more sensitive imaging information but still faces great challenges. Here we report a novel approach for the synthesis of ultra-small Fe3O4 nanoparticles conjugated with c(RGDyK) and their applications as active-target T1-weighted magnetic resonance imaging (MRI) contrast agent (T1-Fe3O4) for imaging tiny hepatic tu  ...[more]

Similar Datasets

| S-EPMC7196312 | biostudies-literature
| S-EPMC7167323 | biostudies-literature
| S-EPMC6572598 | biostudies-literature
| S-EPMC4476954 | biostudies-literature
| S-EPMC4911575 | biostudies-literature
| S-EPMC5759964 | biostudies-literature
| S-EPMC3942367 | biostudies-literature
| S-EPMC6354548 | biostudies-literature
| S-EPMC10060054 | biostudies-literature
| S-EPMC3359512 | biostudies-other